276.

Frantzi M, Latosinska A, Kontostathi G, Mischak H.

Clinical Proteomics: Closing the Gap from Discovery to Implementation.

Proteomics. 2018 Jul;18(14):e1700463. doi: 10.1002/pmic.201700463. Epub 2018 Jul 8.

PMID: 29785737

View Abstract:  Request Reprint

 

213.

Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.
PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015.

View Abstract     Request Reprint

 

205.

Pejchinovski M, Klein J, Ramírez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Mullen W, Mischak H, Jankowski V.
Comparison of higher-energy collisional dissociation and collision-induced dissociation MS/MS sequencing methods for identification of naturally occurring peptides in human urine.
Proteomics Clin Appl. 2015 Mar 27. doi: 10.1002/prca.201400163. [Epub ahead of print]

View Abstract     Request Reprint

 

199.
Nally JE, Mullen W, Callanan JJ, Mischak H, Albalat A.
Detection of urinary biomarkers in reservoir hosts of leptospirosis by capillary electrophoresis mass spectrometry.
Proteomics Clin Appl. 2015 Mar 3. doi: 10.1002/prca.201400205. [Epub ahead of print]

View Abstract     Request Reprint

 

197.

Pontillo C, Filip S, Borràs DM, Mullen W, Vlahou A, Mischak H. Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400115. [Epub ahead of print]
CE-MS-based proteomics in biomarker discovery and clinical application.
Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400115. [Epub ahead of print]

View Abstract     Request Reprint

 

196.

Pejchinovski M, Hrnjez D, Ramírez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Zürbig P, Mischak H, Metzger J, Koeck T.
Capillary zone electrophoresis on-line coupled to mass spectrometry: a perspective application for clinical proteomics.
Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400113. [Epub ahead of print]

View Abstract     Request Reprint

 

182.

Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés A, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H.
Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014.

View Abstract     Request Reprint

 

177.

Mischak H1, Vlahou A2, Righetti PG3, Calvete JJ4.
Putting value in biomarker research and reporting.
J Proteomics. 2014 Jan 16;96:A1-3. doi: 10.1016/j.jprot.2013.12.002.

View Abstract     Request Reprint

 

176.

Albalat A, Husi H, Stalmach A, Schanstra JP, Mischak H.
Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.
Bioanalysis. 2014 Jan;6(2):247-66. doi: 10.4155/bio.13.313.

View Abstract     Request Reprint

 

173.

Klein J, Papadopoulos T, Mischak H, Mullen W.
Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine.
Electrophoresis. 2013 Oct 8. doi: 10.1002/elps.201300327. [Epub ahead of print]

View Abstract     Request Reprint

 

171.

Mermelekas G, Makridakis M, Koeck T, Vlahou A.
Redox proteomics: from residue modifications to putative biomarker identification by gel- and LC-MS-based approaches.
PMID: 24206227 [PubMed - in process]

View Abstract     Request Reprint

 

162.

Suárez ER, Siwy J, Zürbig P, Mischak H.
Urine as a source for clinical proteome analysis: From discovery to clinical application.
Biochim Biophys Acta. 2013 Jul 2. pii: S1570-9639(13)00253-7. doi: 10.1016/j.bbapap.2013.06.016. [Epub ahead of print]

View Abstract     Request Reprint

 

160.

Klein G, Schanstra JP, Hoffmann J, Mischak H, Siwy J
Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
PLoS ONE 8(6): e66682. doi:10.1371/journal.pone.0066682

View Abstract     Request Reprint

 

156.

Stalmach A, Albalat A, Mullen W, Mischak H.
Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.
Electrophoresis. 2013 Jun;34(11):1452-64. doi: 10.1002/elps.201200708. Epub 2013 May 8. 

View Abstract     Request Reprint

 

155.

Klein J, Eales J, Zürbig P, Vlahou A, Mischak H, Stevens R.
Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally-occurring peptide generation.
Proteomics. 2013 Apr;13(7):1077-82. doi: 10.1002/pmic.201200493. Epub 2013 Feb 26. 
         
View Abstract     Request Reprint

 

150.

Mischak H, Vlahou A, Ioannidis JP.
Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience.
Clin Biochem. 2013 Apr;46(6):432-43. doi: 10.1016/j.clinbiochem.2012.09.025. Epub 2012 Oct 4.
         
View Abstract     Request Reprint

 

149.

Albalat A, Franke J, Gonzalez J, Mischak H, Zürbig P.
Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease.
Methods Mol Biol. 2013;919:203-13.
         
View Abstract     Request Reprint

 

144.

 Molin L, Seraglia R, Lapolla A, Ragazzi E, Gonzalez J, Vlahou A, Schanstra JP, Albalat A, Dakna M, Siwy J, Jankowski J, Bitsika V, Mischak H, Zürbig P, Traldi P.
 A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.
J Proteomics. 2012 Oct 22;75(18):5888-97. doi: 10.1016/j.jprot.2012.07.024. Epub 2012 Jul 26.
         
View Abstract     Request Reprint

 

143.

Mischak H
How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS.
Proteomics Clin Appl. 2012 Jul 23. doi: 10.1002/prca.201200027. [Epub ahead of print]
         
View Abstract     Request Reprint

 

139.

Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.
Implementation of proteomic biomarkers: making it work.
Eur J Clin Invest. 2012 Sep;42(9):1027-1036. doi: 10.1111/j.1365-2362.2012.02674.x. Epub 2012 Apr 21.          

View Abstract     Request Reprint

 

138.

Mullen W, Albalat A, Gonzalez J, Zerefos P, Siwy J, Franke J, Mischak H.
Performance of different separation methods interfaced in the same MS-reflection TOF detector: A comparison of performance between CE versus HPLC for biomarker analysis.
Electrophoresis. 2012 Feb;33(4):567-74. doi: 10.1002/elps.201100415.
         
View Abstract     Request Reprint

 

130.

Albalat A, Mischak H, Mullen W.
Clinical application of urinary proteomics/peptidomics.
Expert Rev Proteomics. 2011 Oct;8(5):615-29.
         
View Abstract     Request Reprint

 

121.

Albalat A, Mischak H, Mullen W
Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
Prilozi. 2011 Jul;32(1):13-44.
         
View Abstract     Request Reprint

 

120.

Siwy J, Mullen W, Golovko I, Franke J, Zürbig P
Human urinary peptide database for multiple disease biomarker discovery.
Proteomics Clin Appl. 2011 Jun;5(5-6):367-74. doi: 10.1002/prca.201000155.
         
View Abstract     Request Reprint

 

119.

Mayer G, Heinze G, Mischak H, Hellemons ME, Heerspink HJ, Bakker SJ, de Zeeuw D, Haiduk M, Rossing P, Oberbauer R
Omics-bioinformatics in the context of clinical data.
Methods Mol Biol. 2011;719:479-97
         
View Abstract     Request Reprint

 

118.

Mischak H, Schanstra JP.
CE-MS in biomarker discovery, validation, and clinical application.
Proteomics Clin Appl. 2011 Feb;5(1-2):9-23. doi: 10.1002/prca.201000058. 11.
         
View Abstract     Request Reprint

 

116.

Siwy J, Vlahou A, Zimmerli LU, Zürbig P, Schiffer E
Clinical proteomics: Current techniques and potential applications in the elderly
Maturitas. 2011 Mar;68(3):233-44
         
View Abstract     Request Reprint

 

113.

Dakna M, Keith H, Kalousis A, Carpentier S, Kolch W, Schanstra JP, Haubitz M, Vlahou A, Mischak H, Girolami M.
Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers.
BMC Bioinformatics. 2010 Dec 10;11:594
         
View Abstract     Request Reprint

 

103.

Mischak H, Kolch W, Aivaliotis M, Bouyssie D, Court M, Dihazi H, Dihazi GH, Franke J, Garin J, de Peredo AG, Iphoefer A, Jänsch L, Lacroix C, Makridakis M, Masselon C, Metzger J, Monsarrat B, Mrug M, Norling M, Novak J, Pich A, Pitt A, Bongcam-Rudloff E, Siwy J, Suzuki H, Thongboonkerd V, Wang L, Zoidakis J, Zuerbig P, Schanstra J, Vlahou A
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.
Proteomics Clinical Applications 2010; 4:464-478
         
View Abstract     Request Reprint  

 

102.

Griner EM, Caino MC, Sosa MS, Colon-Gonzalez F, Chalmers MJ, Mischak H, Kazanietz MG
A novel cross-talk in diacylglycerol signaling: the Rac-GAP {beta}2-chimaerin is negatively regulated by PKC{delta} mediated phosphorylation.
J Biol Chem. 2010 May 28;285(22):16931-41
         
View Abstract     Request Reprint

 

101.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D’Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman R, Ioannidis JPA, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovsk G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra T, Weissinger E, Yamamoto T, Vlahou A
Recommendations for biomarker identification and qualification in clinical proteomics.
Science Translational Medicine Papers 2010
         
View Abstract     Request Reprint 

 

94.

Zürbig P, Schiffer E, Mischak H.
Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery
Methods Mol Biol. 2009;564:105-21
     
View Abstract     Request Reprint  

 

92.

Dhillona AS, Yipa YY, Grindlay GJ, Pakaya JL, Dangers M, Hillmann M, Clark W, Pitte A, Mischak H, Kolch W
The C-terminus of RAF-1 acts as a 14-3-3-dependent activation switch
Cell Signal. 2009 Nov;21(11):1645-51
       
View Publisher Website     Request Reprint  

 

91.

Jankowski V, Giet M, Mischak H, Morgan M, Zidekm W, Jankowski J
Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system (review)
Br J Pharmacol 2009 Aug;157(7):1142-53
         
View Publisher Website     Request Reprint  

 

85.

Metzger J, Luppa PB, Good DM, Mischak H
Adapting mass spectrometry-based platforms for clinical proteomics applications: the capillary electrophoresis coupled mass spectrometry paradigm
Crit Rev Clin Lab Sci. 2009;46(3):129-52
         
View Publisher Website     Request Reprint  

 

83.

Dakna M, He Z, Yu WC, Mischak H, Kolch W
Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment
Journal of Chromatography B 2009, 877(13): 1250-1258
         
View Abstract     Request Reprint  

79.

Schiffer E, Mischak H, Zimmerli LU
Proteomics in gerontology - current applications and future aspects
Gerontology. 2009;55(2):123-37. Epub 2009 Jan 9.
         
View Abstract     Request Reprint  

77.

Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra J, Dominiczak AF
Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments
Mass Spectrom Rev. 2009 Sep-Oct;28(5):703-24.
         
View Abstract     Request Reprint  

75.

Metzger J, Schanstra JP, Mischak H
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments
Anal Bioanal Chem. 2009 Mar;393(5):1431-42. Epub 2008 Aug 15.
         
View Abstract     Request Reprint  

73.

Vlahou A, Schanstra J, Frokiaer J, El Nahas M, Spasovski G, Mischak H, Domon B, Allmaier G, Bongcam-Rudloff E, Attwood T; On behalf of the European Kidney and Urine Proteomics Network
Establishment of a European Network for Urine and Kidney Proteomics
J Proteomics 2008, 71(4): 490-492
         
View Abstract     Request Reprint  

72.

Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP
Urine in clinical proteomics
Mol Cell Proteomics 2008, 7(10): 1850-1862
         
View Abstract     Request Reprint  

71.

Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jenoe P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Doehner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease
Proc Natl Acad Sci (USA) 2008, 105(32): 11299-11304
         
View Abstract     Request Reprint  

70.

Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J
A bench to bedside view of uremic toxins
J Am Soc Nephrol. 2008, 19: 863-870
         
View Abstract     Request Reprint  

69.

Coon JJ, Zurbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
PROTEOMICS - Clinical Applications 2008, 2(7-8): 964-973
         
View Abstract     Request Reprint  

60.

Mathivanan S, et al., Mischak H, et al., Zurbig P, Pandey A
Human Proteinpedia: A portal for sharing and integration of human protein data
Nature Biotechnology 2008, 26(2): 164-167
         
View Abstract     Request Reprint  

58.

Goodsaid F, Bandow JE, Mischak H
REPORT - Grand Rounds in Proteomics at the FDA (White Oak, Silver Spring, MD, USA, April 3, 2007)
PROTEOMICS - Clinical Applications 2007, 1: 1526-1531
         
View Abstract     Request Reprint  

57.

Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H
Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future
J Proteome Res. 2007, 6(12): 4549-4555
         
View Abstract     Request Reprint  

53.

Geppert HG, Mischak H
Klinische Proteomanalyse zur effektiven Gesundheitsvorsorge
journal of preventive medicine 2007, 3(3+4): 330-337
         
View Abstract     Request Reprint  

52.

Geppert HG
Polypeptide zeigen pathologische Prozesse
Nachrichten aus der Chemie 2007, 55: 1020-1021
         
View Abstract     Request Reprint  

49.

Theodorescu D, Mischak H
Mass spectrometry based proteomics in urine biomarker discovery
World J Urol. 2007, 25(5): 435-443
         
View Abstract     Request Reprint  

45.

Sniehotta M, Schiffer E, Zurbig P, Novak J, Mischak H
CE - a multifunctional application for clinical diagnosis
Electrophoresis 2007, 28(9): 1407-1417
         
View Abstract     Request Reprint  

42.

Ehrich J, Mischak A, Mischak H
Proteomanalyse
Österreichische Ärztezeitung 2007, 6: 49-53
         
View Abstract     Request Reprint  

40.

Mischak H, Julian BA, Novak A
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine
PROTEOMICS - Clinical Applications 2007, 1: 792-804
         
View Abstract     Request Reprint  

39.

Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JHH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, Neusuess C, Novak J, Peter K, Rossing K, Schanstra J, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, van Eyk JE, Yamamoto T
Clinical Proteomics: a need to define the field and to begin to set adequate standards
PROTEOMICS - Clinical Applications 2007, 1: 148-156
         
View Abstract     Request Reprint  

37.

Schiffer E, Mischak H, Novak J
High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS
Proteomics 2006, 6(20): 5615-5627
         
View Abstract     Request Reprint  

35.

Zurbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neususs C, Theodorescu D, Root KE, Ross MM, Mischak H
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation
Electrophoresis 2006, 27(11): 2111-2125
         
View Abstract     Request Reprint  

29.

Thongboonkerd V, Cutillas PR, Unwin RJ, Schaub S, Nickerson P, Haubitz M, Mischak H, Nedelkov D, Kiernan U, Nelson RW
Proteomics of Human Urine
Thongboonkerd V (Ed.) 2006, Proteomics of Human Body Fluids: Principles, Methods, and Applications
         
View Abstract     Request Reprint  

27.

Girolami M, Mischak H, Krebs R
Analysis of complex, multidimensional datasets
Drug Dicovery Today: Analytical technologies 2006, 3(1): 13-19
         
View Abstract     Request Reprint  

26.

Kolch W, Neususs C, Pelzing M, Mischak H
Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery
Mass Spectrom Rev. 2005, 24(6): 959-977
         
View Abstract     Request Reprint  

24.

Weissinger EM, Hertenstein B, Mischak H, Ganser A
Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis
Expert Reviews In: Proteomics 2005, 2(5): 639-647
         
View Abstract     Request Reprint  

19.

Fliser D, Wittke S, Mischak H
Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes
Electrophoresis. 2005, 26(14): 2708-2716
         
View Abstract     Request Reprint  

14.

Walden M, Mischak H
Proteomanalyse mittels Kapillarelektrophorese-gekoppelter Massenspektrometrie - ein neues Routineverfahren in der klinischen Diagnostik?
Klinische Chemie Mitteilungen 2005, 36(5): 87-101
         
View Abstract     Request Reprint  

11.

Kolch W, Mischak H, Chalmers MJ, Pitt A, Marshall AG
Clinical proteomics: a question of technology
Rapid Commun Mass Spectrom. 2004, 18(19): 2365-2366
         
View Abstract     Request Reprint  

10.

Kaiser T, Wittke S, Just I, Krebs R, Bartel S, Fliser D, Mischak H, Weissinger EM
Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use
Electrophoresis 2004, 25(13): 2044-2055
         
View Abstract     Request Reprint  

6.

Wittke S, Kaiser T, Mischak H
Differential polypeptide display: the search for the elusive target
J Chromatogr B Analyt Technol Biomed Life Sci. 2004, 803(1): 17-26
         
View Abstract     Request Reprint  

5.

Chalmers MJ, Kolch W, Emmett MR, Marshall AG, Mischak H
Identification and analysis of phosphopeptides
J Chromatogr B Analyt Technol Biomed Life Sci. 2004, 803(1): 111-120
         
View Abstract     Request Reprint  

4.

Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, Sundmacher A, Schlegelberger B, Kolch W, Mischak H
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry
Rapid Commun Mass Spectrom. 2004, 18(2): 149-156
         
View Abstract     Request Reprint  

1.

Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, Hausadel F, Hillmann M, Golovko I, Koester P, Haller H, Kaiser T, Mischak H, Weissinger EM
Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers
J Chromatogr A. 2003, 1013(1-2): 173-181
         
View Abstract     Request Reprint